MedTrace Logo

Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users

NCT02342470 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2018-01-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety by comparing prevention of recurrent peptic ulcer in low-dose aspirin users between PMK-S005 and Placebo.

Conditions

  • Peptic Ulcer

Interventions

DRUG

Placebo

Drug : Placebo

DRUG

PMK-S005 1

Drug : PMK-S005 1 (50mg)

DRUG

PMK-S005 2

Drug : PMK-S005 2 (100mg)

DRUG

PMK-S005 3

Drug : PMK-S005 3 (150mg)

Sponsors & Collaborators

  • PharmaKing

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-24
Primary Completion
2017-12-08
Completion
2017-12-08

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02342470 on ClinicalTrials.gov